BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19863531)

  • 21. Saturation biopsies for prostate cancer detection: effectiveness, safety and predictive factors.
    Utrera NM; Sánchez AT; Rodríguez-Antolín A; Martín-Parada A; Lora D; Passas J; González RD
    Arch Esp Urol; 2011 Jun; 64(5):421-6. PubMed ID: 21705814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of prostate cancer on extended biopsy in patients with high-grade prostatic intraepithelial neoplasia: a multivariate analysis model.
    Abdel-Khalek M; El-Baz M; Ibrahiem el-H
    BJU Int; 2004 Sep; 94(4):528-33. PubMed ID: 15329106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5-20 ng/ml in Japan.
    Yamamoto S; Kin U; Nakamura K; Hamano M; Nishikawa Y; Takenouchi T; Maruoka M
    Int J Clin Oncol; 2005 Apr; 10(2):117-21. PubMed ID: 15864697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How many cores should be taken in a repeat biopsy on patients in whom atypical small acinar proliferation has been identified in an initial transrectal prostate biopsy?
    Aglamis E; Kocaarslan R; Yucetas U; Toktas G; Ceylan C; Doluoglu OG; Unluer E
    Int Braz J Urol; 2014; 40(5):605-12. PubMed ID: 25498271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner.
    Singh AK; Krieger A; Lattouf JB; Guion P; Grubb RL; Albert PS; Metzger G; Ullman K; Smith S; Fichtinger G; Ocak I; Choyke P; Ménard C; Coleman J
    BJU Int; 2008 Jan; 101(2):181-5. PubMed ID: 17922874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience.
    Pinkstaff DM; Igel TC; Petrou SP; Broderick GA; Wehle MJ; Young PR
    Urology; 2005 Apr; 65(4):735-9. PubMed ID: 15833518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
    Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
    Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
    Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
    BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection.
    Watanabe M; Hayashi T; Tsushima T; Irie S; Kaneshige T; Kumon H
    Int J Urol; 2005 Nov; 12(11):959-63. PubMed ID: 16351651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
    Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
    Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies.
    Pryor MB; Schellhammer PF
    Clin Prostate Cancer; 2002 Dec; 1(3):172-6. PubMed ID: 15046692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The implication of initial 24-core transrectal prostate biopsy protocol on the detection of significant prostate cancer and high grade prostatic intraepithelial neoplasia.
    Nomikos M; Karyotis I; Phillipou P; Constadinides C; Delakas D
    Int Braz J Urol; 2011; 37(1):87-93; discussion 93. PubMed ID: 21385484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
    Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
    J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
    Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
    BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
    Stewart CS; Leibovich BC; Weaver AL; Lieber MM
    J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-enhanced colour Doppler-targeted vs a 10-core systematic repeat biopsy strategy in patients with previous high-grade prostatic intraepithelial neoplasia.
    Mitterberger M; Horninger W; Aigner F; Pinggera GM; Rehder P; Steiner E; Wiunig C; Reissigl A; Frauscher F
    BJU Int; 2010 Jun; 105(12):1660-2. PubMed ID: 19863528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy.
    Roscigno M; Scattoni V; Freschi M; Raber M; Colombo R; Bertini R; Montorsi F; Rigatti P
    Urology; 2004 Jun; 63(6):1105-10. PubMed ID: 15183961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
    BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.